Literature DB >> 19786751

Inflammatory bowel diseases: controversies in the use of diagnostic procedures.

Boris Vucelic1.   

Abstract

The term inflammatory bowel disease (IBD) denotes a genetically, immunologically and histopathologically heterogeneous group of inflammatory bowel disorders classified at present time as ulcerative colitis (UC), Crohn's disease (CD) and indeterminate colitis (IC). Diagnosis of IBD is based on a non-strictly defined combination of clinical and diagnostic parameters. In order to guide the treatment, patients must be assessed by determining IBD phenotype, disease extension and distribution, extraintestinal manifestations, disease behavior, disease severity and drug responsiveness. Each element of the diagnostic process cannot be looked at alone, but has to be incorporated into general clinical assessment, bearing in mind that different phenotypes and age groups require specific diagnostic solutions. Advances in technology provided the possibility for the assessment of the entire digestive system with endoscopy leading the way. Sophisticated imaging methods made the analysis of the bowel wall with its vascularity and adjacent mesentery possible. The challenge is still the small bowel, where a combination of endoscopy and imaging methods is used. The use of imaging methods should be, among other things, guided by level of irradiation which is especially important in young patients and in patients requiring repeated investigations. Using abdominal ultrasound as a low-cost, noninvasive procedure, one has to take into account that it is very operator-dependent method. In UC, endoscopy is used for the evaluation of the extent and activity of the disease and to assess complications like stricture, dysplasia and cancer. UC is classified by the disease extent into proctitis, left-sided colitis and extensive colitis beyond the splenic flexure. Pediatric patients with UC have more extensive disease than adults with rectal sparing in up to 30% of patients. The severity of mucosal changes are reported as Baron endoscopic score. Endoscopic findings correlate well with clinical activity and are commonly incorporated into Mayo index, combination of clinical Truelove Witts index and Baron score. Complications like strictures require imaging methods as supplement to endoscopy. The incidence of CD, particularly in children and adolescents, has risen during the past decade, with children often having extensive and severe disease The nature of CD requires the use of wide array of endoscopic and imaging methods, placed properly in the diagnostic algorithms for specific disease phenotypes and complications and adapted for specific age groups. Endoscopic features of CD are very variable and can be quantified as Crohn's Disease Endoscopic Index of Severity (CDEIS) or Simple Endoscopic Score for CD (SES-CD). Disease activity is most commonly assessed by CDAI. Perianal disease activity should be measured by PDAI due to low CDAI scores in these patients. The activity of CD in children should be assessed by the Pediatric Activity Index. IC is part of the IBD spectrum where chronic colitis cannot be defined as either UC or CD after sequential colonoscopies and colonic biopsies or at colectomy. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19786751     DOI: 10.1159/000228560

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  23 in total

Review 1.  Newer CT applications and their alternatives: what is appropriate in children?

Authors:  R Paul Guillerman
Journal:  Pediatr Radiol       Date:  2011-08-17

Review 2.  Role of MiRNAs in Inflammatory Bowel Disease.

Authors:  Bo Cao; Xin Zhou; Jiaojiao Ma; Wei Zhou; Wanli Yang; Daiming Fan; Liu Hong
Journal:  Dig Dis Sci       Date:  2017-04-08       Impact factor: 3.199

3.  Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity.

Authors:  K A Oikonomou; A N Kapsoritakis; C Theodoridou; D Karangelis; A Germenis; I Stefanidis; S P Potamianos
Journal:  J Gastroenterol       Date:  2011-12-27       Impact factor: 7.527

4.  FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity.

Authors:  Babak Saboury; Ali Salavati; Alex Brothers; Sandip Basu; Thomas C Kwee; Marnix G E H Lam; Roland Hustinx; Edouard Louis; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-20       Impact factor: 9.236

5.  Comparison between quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound and results of histopathological scoring in ulcerative colitis.

Authors:  Christiane Girlich; Doris Schacherer; Ernst Michael Jung; Frank Klebl; Elisabeth Huber
Journal:  Int J Colorectal Dis       Date:  2011-08-17       Impact factor: 2.571

6.  Comparison of MR enterography and histopathology in the evaluation of pediatric Crohn disease.

Authors:  Jonathan R Dillman; Maria F Ladino-Torres; Jeremy Adler; Vera DeMatos-Malliard; Jonathan B McHugh; Shokoufeh Khalatbari; Peter J Strouse
Journal:  Pediatr Radiol       Date:  2011-07-23

Review 7.  Diet, gut microbes, and genetics in immune function: can we leverage our current knowledge to achieve better outcomes in inflammatory bowel diseases?

Authors:  Vanessa A Leone; Candace M Cham; Eugene B Chang
Journal:  Curr Opin Immunol       Date:  2014-09-15       Impact factor: 7.486

Review 8.  Diagnostic imaging advances in murine models of colitis.

Authors:  Markus Brückner; Philipp Lenz; Marcus M Mücke; Faekah Gohar; Peter Willeke; Dirk Domagk; Dominik Bettenworth
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 9.  Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: where are we now in the era of the next generation proteomics?

Authors:  Jong-Min Park; Na Young Han; Young-Min Han; Mi Kyung Chung; Hoo Keun Lee; Kwang Hyun Ko; Eun-Hee Kim; Ki Baik Hahm
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

10.  Comparison of multiple enzyme activatable near-infrared fluorescent molecular probes for detection and quantification of inflammation in murine colitis models.

Authors:  Shengli Ding; Randal E Blue; Douglas R Morgan; Pauline K Lund
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.